(NYSE: LLY) Eli Lilly & Co's forecast annual revenue growth rate of 13.56% is forecast to beat the US Drug Manufacturers - General industry's average forecast revenue growth rate of 7.53%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.36%.
Eli Lilly & Co's revenue in 2026 is $79,665,800,000.On average, 33 Wall Street analysts forecast LLY's revenue for 2026 to be $84,431,256,516,915, with the lowest LLY revenue forecast at $79,250,968,588,220, and the highest LLY revenue forecast at $90,559,491,010,065. On average, 33 Wall Street analysts forecast LLY's revenue for 2027 to be $97,773,110,199,160, with the lowest LLY revenue forecast at $86,628,383,906,625, and the highest LLY revenue forecast at $109,220,953,466,625.
In 2028, LLY is forecast to generate $109,518,422,299,165 in revenue, with the lowest revenue forecast at $95,390,535,467,645 and the highest revenue forecast at $128,104,576,190,525.